Angiostatic steroids. Method of discovery and mechanism of action
- PMID: 2443088
- PMCID: PMC1493178
- DOI: 10.1097/00000658-198709000-00016
Angiostatic steroids. Method of discovery and mechanism of action
Abstract
A new class of steroids has been found that inhibits angiogenesis in the presence of nonanticoagulant heparin. Tetrahydrocortisol is the most potent of the naturally occurring angiostatic steroids. It is a metabolite of cortisone that circulates in the blood, appears in the urine, and was previously believed to be biologically inactive. Both the plasma form and the urinary form are antiangiogenic. The mechanism of action of these steroids depends on their ability to specifically alter basement membrane turnover in growing capillary blood vessels. These steroids represent a prototype of angiogenesis inhibitors that may find potential therapeutic use as adjuncts to anticancer therapy, and in diseases dominated by abnormal neovascularization, i.e., angiogenesis-dependent diseases.
Similar articles
-
A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.Science. 1985 Dec 20;230(4732):1375-8. doi: 10.1126/science.2416056. Science. 1985. PMID: 2416056
-
A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.Endocrinology. 1986 Oct;119(4):1768-75. doi: 10.1210/endo-119-4-1768. Endocrinology. 1986. PMID: 2428602
-
Inhibition of angiogenesis through modulation of collagen metabolism.Lab Invest. 1988 Jul;59(1):44-51. Lab Invest. 1988. PMID: 2455830
-
Angiogenesis: an update.Histol Histopathol. 1994 Oct;9(4):807-43. Histol Histopathol. 1994. PMID: 7534514 Review.
-
How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.Cancer Res. 1986 Feb;46(2):467-73. Cancer Res. 1986. PMID: 2416426 Review. No abstract available.
Cited by
-
Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.Am J Pathol. 2007 Sep;171(3):1058-65. doi: 10.2353/ajpath.2007.070172. Epub 2007 Aug 9. Am J Pathol. 2007. PMID: 17690185 Free PMC article.
-
Tumour vasculature--a potential therapeutic target.Br J Cancer. 1995 Aug;72(2):257-67. doi: 10.1038/bjc.1995.323. Br J Cancer. 1995. PMID: 7543770 Free PMC article. Review.
-
A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).Cancer Metastasis Rev. 1996 Jun;15(2):247-72. doi: 10.1007/BF00437479. Cancer Metastasis Rev. 1996. PMID: 8842498 Review. No abstract available.
-
Evaluation of angiogenic inhibitors with an in vivo quantitative angiogenesis method using agarose microencapsulation and mouse hemoglobin enzyme-linked immunosorbent assay.Jpn J Cancer Res. 1996 Sep;87(9):952-7. doi: 10.1111/j.1349-7006.1996.tb02125.x. Jpn J Cancer Res. 1996. PMID: 8878458 Free PMC article.
-
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.J Clin Invest. 1993 May;91(5):2235-43. doi: 10.1172/JCI116450. J Clin Invest. 1993. PMID: 7683699 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources